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Background: Sickness absence is a public health problem with economic consequences for individuals and society.
Although sickness absence and chronic diseases are correlated, few studies exist concerning the role of chronic
disease in all-cause sickness absence. The aim was to assess the cumulative incidence of sickness absence and
examine the accompanying burden of chronic diseases among the sick-listed.
Methods: A cross-sectional study was performed with data from 2008. Cumulative incidence of all-cause sickness
absence (≥14 days) was calculated based on all newly sick-listed individuals (N = 12,543). The newly sick-listed
sample and a randomized general population sample (n = 7,984) received a questionnaire (participation rates: 54%
and 50%).To assess the burden of self-reported chronic diseases, standardized incidence ratios (SIR) were calculated.
Results: Estimated one-year cumulative incidence was 11.3% (95% CI: 11.2–11.3), 14.0% (13.9–14.1) for women and
8.6% (8.5–8.6) for men. Gender differences were consistent across all age groups, with highest cumulative incidence
among women aged 51–64 years, 18.2% (18.0–18.5). For women, the burden of chronic disease was significantly higher
for nine out of twelve disease groups, corresponding numbers for men were nine out of eleven disease groups
(standardized for age and socio-economic status). Neoplastic diseases had the highest SIR with 4.3 (3.4–5.2) for women
and 4.2 (2.8–5.6) for men. For psychiatric and rheumatic diseases the respective SIR’s were 1.7 for women and 1.8 for
men. The remaining disease groups had an elevated risk of 20-60% (SIR 1.2–1.6). The risk of reporting a co-morbidity
was increased for women (SIR 1.4 (95% CI 1.4–1.5)) and men (SIR 1.5 (1.4–1.7)) among the sick-listed.
Conclusions: Register data was used to estimate of the cumulative incidence of sickness absence in the general
population. A higher burden of chronic disease among the newly sick-listed was found. Targeting long-term health
problems may be an important public health strategy for reducing sickness absence.
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Sickness absence in Sweden is higher than in other
Northern European countries [1] possibly related to
higher employment rates, particularly among women
and older workers [2], thus including a larger proportion
of employees with underlying health problems [3]. An
OECD report from 2006 on sickness absence in Sweden
stated an urgent need to address the “medicalisation” of
the labour market [4]. This refers to the inclusion of in-
dividuals absent for other reasons than illness amongst* Correspondence: brynja@gmail.com
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distribution, and reproduction in any mediumthe sick-listed, diverting focus from health towards other
factors contributing to sickness absence. It has been pro-
posed that high sickness absence in Sweden portrays
concealed unemployment [5]. The level of sickness ab-
sence in Sweden is considered both a public health and
an economic problem due to marginalization of individ-
uals, benefit payments and production loss [6,7]. How-
ever, sickness absence is a multifactorial phenomenon,
not only dependent on the current illness causing the
sickness absence episode, but also various other factors
such as the psychosocial and physical work environment,
family support and the general health status of the indi-
vidual [8-10]. Sickness absence can be seen as an inte-
grated measure of physical, psychological, and socialCentral Ltd. This is an Open Access article distributed under the terms of the
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Sweden generally have a higher sickness absence rate
compared to men [12]. This has not been seen in all
countries, age groups or professions and seems more
prominent in short-term absences [13,14]. Another im-
portant aspect is the social gradient observed in sickness
absence, with higher rates for lower socio-economic
groups [15,16]. Furthermore, sickness absence has been
related to future adverse health outcomes, mortality and
subsequent lower self-rated health for up to 14 years, ir-
respective of self-reported chronic conditions [17-19].
Other studies have found that sickness absence increases
the future risk of disability pension [20,21] and that sick
leave lasting longer than three weeks is associated with
poor self-reported health, physical complaints, low men-
tal well-being and poor work ability [22].
In light of the “medicalisation” of the labour market pre-
viously mentioned, surprisingly few studies have examined
the health status of individuals with all-cause sickness ab-
sence. Chronic diseases and sickness absence appear to be
correlated and chronic disease can predict long-term sick-
ness absence and disability pension [23,24]. The presence
of at least one long term disease predicts long term sick-
ness absence [25,26] and the risk of sickness absence
seems to be even higher for those with a co-morbid dis-
ease [24,27,28]. To decrease the rates of sickness absence
it is important to acquire accurate information on the
newly sick-listed employed population, which is at risk of
proceeding into long term sickness absence. Correct infor-
mation on the incidence of sickness absence as well as the
health status of the sick-listed individuals is essential so
that resource distribution and preventive measures can be
focused on those at risk.
The aim of this study was to assess the cumulative in-
cidence of sickness absence, and to estimate and com-
pare the burden of chronic disease among the newly
sick-listed and the general population. The hypothesis
was that the burden of underlying chronic disease is
higher among newly sick-listed individuals than the gen-
eral population.
Methods
The current study design was cross-sectional and part of
the Health Assets Project (HAP) [29] initiated in 2008.
The main purpose of HAP was to examine the influence
of individual, organizational, and societal factors on health,
sickness absence, and return to work. The study base was
the population of Västra Götaland region in Sweden
(approximately 1.6 million inhabitants, representing 17%
of the Swedish population) and included both urban and
rural areas.
The present study was divided into two parts. The first
part was register-based including all employed individ-
uals (n=12,543) who had one sick-leave spell ≥14 days,during the period 18th of February to 15th of April 2008.
The second part of the study was questionnaire-based and
examined the self-reported chronic diseases in a sample of
the newly sick-listed and a random sample from the gen-
eral population obtained with the help of Statistics Sweden.
The newly sick-listed sample (n=6,140) consisted of all in-
dividuals who were registered as sick-listed at the Social In-
surance during the inclusion period of February to 15th of
April 2008. The sample constitutes 49 % of those who be-
came sick-listed during the period. The remaining 51%
(n=6,403) became sick-listed during the time period but
were, due to administrative reasons registered after the 15th
of April 2008. This group was not invited to the question-
naire study since we aimed at distributing the question-
naire as close as possible to the actual sick-leave period.
The register study was based on official statistics and did
not include any individual level data. Participation in the
questionnaire study was based on informed consent. Both
the register- and questionnaire-based parts of this study
were approved by the Regional Ethical Review Board in
Gothenburg, Sweden (Dnr: 039–08) and conducted in ac-
cordance with the latest version of the Helsinki protocol.
Study population
To assess cumulative incidence the population at risk was
used as denominator and consisted of all employed indi-
viduals aged 19–64 years (N = 668,887) living in the
region (Table 1). All employed individuals who became
sick-listed ≥ 14 days (N = 12,543) during the inclusion
period constituted the numerator. Sickness absences last-
ing two weeks or less are employer-paid and therefore not
registered by the Swedish Social Insurance Agency [30].
Denominator information was retrieved from Statistics
Sweden and numerator information from the Swedish
Social Insurance Agency.
In the second part of the study, 49 % of the newly
sick-listed employed population (n = 6,140) and a ran-
dom sample of the general population (n = 7,984) were
invited to participate in a questionnaire study. Respon-
dents to the questionnaire comprised the two samples,
the newly sick-listed sample (n = 3,310) and the general
population sample (n = 4,027). The characteristics and
socio-demographic data of the population at risk, the
newly sick-listed population as well as respondents to
the questionnaire can be seen in Table 1.
The participation rate in the newly sick-listed sample was
54% (n = 3,310), yielding a response rate of 58% (n = 2,196)
for women and 47% (n = 1,114) for men. The participation
rate in the general population sample was 50% (n = 4,027),
55% (n = 2,234) for women and 45% (n = 1,793) for men.
Non-response in both sample groups was more likely in
the youngest age group (19–30 years), the lowest annual in-
come group, ≤149,000 SEK, and amongst those born out-
side the Nordic countries.
Table 1 Characteristics and socio-demographic data of the population at risk and the study samples
Population at risk Newly sick-listed population General population sample
Men
N = 336 085
Women
N = 332 802
Men
n = 2 386
Women
n = 3 754
Men
n = 4 086
Women
n = 3 898
Non-responders (percentage of sample) # # 1 272 (53) 1 558 (42) 2 293 (56) 1 664 (43)
Participants # # n =1 113 n =2 196 n =1 793 n = 2 234
N (%) N (%) n (%) n (%) n (%) n (%)
Age
19-30 years 83 474 (25) 76 588 (23) 129 (12) 251 (11) 366 (20) 464 (21)
31-50 years 163 719 (49) 162 391 (49) 445 (40) 1034(47) 802 (45) 1001 (45)
51-64 years 88 892 (26) 93 823 (28) 539 (48) 912 (42) 625 (35) 769 (34)
Socio-economic group
Higher non-manual employees ° ° 114 (10) 245 (11) 328 (18) 308 (14)
Intermediate non-manual employees ° ° 169 (15) 597 (27) 369 (21) 574 (26)
Lower non-manual employees ° ° 73 (7) 315 (14) 159 (9) 365 (16)
Skilled worker ° ° 317 (28) 462 (21) 374 (21) 345 (15)
Unskilled worker ° ° 409 (37) 550 (25) 408 (23) 478 (21)
Other ° ° 0 (0) 0 (0) 64 (4) 55 (2)
Information on socio-economic status missing ° ° 31 (3) 28 (1) 91 (5) 109 (5)
#Inapplicable since questionnaire was not sent out to the entire population at risk. °Information on socio-economic status of the population at risk was not available.
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A self-administered questionnaire was mailed by Statis-
tics Sweden to the two samples. The questionnaire in-
cluded items on socio-demographic factors, physical and
mental health, sick-leave, working life, family conditions,
life-events, leisure and lifestyle and is included as an
additional file [see Additional file 1].
Burden of chronic diseases was assessed using the fol-
lowing question: “Do you have a persistent disease, prob-
lem or disability?” Response options were given as a check
list of eleven different disease groups (cardiovascular, pul-
monary, dermatologic, musculoskeletal, rheumatic, neuro-
logic, psychiatric, endocrine, neoplastic, gastrointestinal
and gynaecologic disease/problem/disability) as well as the
alternatives “no” and “other”. Participants who replied
“other” then had the opportunity to provide their own an-
swer. These answers were categorized into the eleven
different disease groups during data processing. The defin-
ition of chronic disease or chronic condition is not agreed
upon in literature. According to the World Health
Organization (WHO) chronic diseases have a long dur-
ation and usually slow progression [31]. The term chronic
disease will be used when referring to the aforementioned
disease groups, even though some of the conditions
reported might not fall under the strictest definitions of
chronic disease.
The participants were divided into three age groups
19–30, 31–50 and 51–64 years. Socioeconomic status
was based on occupational position derived from Statis-
tics Sweden register data and categorized according to
their definitions [32]. Forty-nine individuals required
manual reclassification into relevant socio-economic
groups based on self-reported data, six individuals in thenewly sick-listed sample were excluded due to missing
information on occupational position and a total of 106
individuals in the newly sick-listed sample and 152 indi-
viduals in the general population sample were excluded
due to missing or internally conflicting answers to the
questions regarding chronic disease.
Statistical analysis
Statistical analysis was performed using IBM SPSS Statis-
tics version 19.0.0 and Microsoft Office Excel 2007. The
two-month cumulative incidence of all-cause sickness ab-
sence was calculated as a fraction of the population at risk:
Cumulative Incidence
¼ Incident cases February 18 th April 15thð Þ
Number of employees in 2008
The one-year cumulative incidence of all-cause sick-
ness absence was then estimated by multiplying the two-
month cumulative incidence by six. Confidence intervals
(CI) were calculated separately for the two-month cu-
mulative incidence and the estimated one-year cumula-
tive incidence [33].
In the second part of the study results for chronic dis-
eases in the two samples were presented as a proportion
out of the sample for each disease group. Proportions were
compared by calculating 95% CI for the difference in pro-
portions [34]. Burden of chronic disease was assessed by
calculating standardized incidence ratios (SIR), where ob-
served number of cases reporting a chronic disease or
condition in the sick-listed population was divided by the
expected number of cases [35]. Standardization was
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age and socioeconomic groups. The expected number of
cases was calculated for the sick-listed sample using pro-
portions derived from the randomized general population
sample results in each group [35]. If the SIR was 1.0 the
incidence in the newly sick-listed sample equalled that of
the general population. The 95% CI of SIR was calculated
and a significant difference between the two samples was
noted when the confidence interval did not include 1.0.Results
Cumulative incidence
The cumulative incidence of all-cause sickness absence
was 1.9% (95% CI 1.8-1.9) for the two-month period which
gave an estimated one-year cumulative incidence of 11.3%
(95% CI 11.2-11.3) (Table 2). The highest one-year cumu-
lative incidence was 18.2% (95% CI 18.0–18.5) for women
aged 51–64 years. The older age groups had a higher cu-
mulative incidence of all-cause sickness absence in gen-
eral. Women had a higher cumulative incidence than men
across all age groups, most prominently in the age group
31–50 years, where women had 1.8 times higher cumula-
tive incidence. The least gender difference was seen
among the youngest age group, 19–30 year olds.Gender differences – self-reported chronic diseases
Among the sick-listed, endocrine disease, musculoskeletal
problems and rheumatic disease were significantly more
often reported by women than men (Table 3). Men reported
having a cardiovascular disease more often than women.
Women were more likely to report more than one chronic
disease or problem compared to men (33.0% vs. 22.1%).
In the youngest age group more women than men
reported psychiatric disease and chronic gastrointestinal
disease, reporting “no chronic disease” was more com-
mon among men than women. In the oldest age group
(51–64 years) men reported having a chronic cardiovas-
cular disease more often than women, while a larger
proportion of women reported chronic musculoskeletal
problems and rheumatic disease compared to men.Table 2 All-cause cumulative incidence of sickness absence am
Age groups 2-month cumulative incidence
All Men Women
N = 668 887 N = 336 085 N = 332 80
% (95% C.I.) % (95% C.I.) % (95% C.I
19-30 1.3 (1.3–1.4) 1.0 (1.0–1.1) 1.7 (1.6–1.8
31-50 1.9 (1.9–2.0) 1.4 (1.3–1.4) 2.5 (2.4–2.5
51-64 2.3 (2.2–2.4) 1.9 (1.8–2.0) 3.0 (2.9–3.2
All ages 1.9 (1.8–1.9) 1.4 (1.4–1.5) 2.3 (2.3–2.4
#1-year cumulative incidence was estimated by multiplying the 2 month cumulativeDisease burden
There was a significantly higher proportion reporting
most chronic disease groups among the newly sick-listed
sample compared with the general population sample
(Figure 1). The chronic condition most commonly
reported by both samples was musculoskeletal disorders
(26.6% newly sick-listed, 17.1% general population). Neo-
plastic disease was reported nearly four times more often
among the newly sick-listed (3.8% newly sick-listed, 0.8%
general population). Rheumatic disease and psychiatric
disease were reported almost twice as often by the newly
sick listed sample (rheumatic disease: 5.3% newly sick
listed, 2.8% general population; psychiatric disease:
10.4% newly sick listed, 5.5% general population). The
proportion reporting no chronic disease among the
newly sick-listed population was 30.5%, while the corre-
sponding figure for the general population was 48.1%.
Co-morbidities were more commonly reported by the
newly sick-listed sample compared with the general
population sample (29.4% newly sick listed, 18.1% gen-
eral population).
When standardized for age, men and women in the
newly sick-listed sample had a significantly higher bur-
den of disease compared with the general population
(Table 4). Women had a significantly higher burden of
disease for eight out of the twelve chronic disease groups
while the corresponding number for men was nine out
of the eleven groups (excluding gynaecological disease).
When standardized for age and socio-economic status,
the burden of disease among the newly sick-listed com-
pared with the general population was significantly
higher for nine out of twelve chronic disease groups for
women and nine out of eleven for men. Among the
more common medical conditions the burden of disease
(SIR) for musculoskeletal disorders was 1.3 for women
and 2.4 for men; gastrointestinal 1.3 for women and 1.6
for men; psychiatric 1.7 for women and 2.1 for men; and
cardiovascular 1.2 for women and 1.4 for men.
Among the less common diseases the highest SIR was
for neoplastic disease (SIR 4.3 for women and 4.2 for men)
followed by rheumatic disease (SIR 1.7 for women and 1.8
for men), endocrine disease (SIR 1.5 for women and 1.5 forong employed individuals aged 19–64 years#
Estimated 1-year cumulative incidence
All Men Women
2 N = 668 887 N = 336 085 N = 332 802
.) % (95% C.I.) % (95% C.I.) % (95% C.I.)
) 8.0 (7.8–8.1) 6.1 (5.9–6.3) 10.0 (9.8–10.3)
) 11.5 (11.4–11.6) 8.3 (8.1–8.4) 14.7 (14.5–14.9)
) 13.7 (13.6–13.9) 11.4 (11.1–11.6) 18.2 (18.0–18.5)
) 11.3 (11.2–11.3) 8.6 (8.5–8.6) 14.0 (13.9–14.1)
incidence by six.
Table 3 Proportion reporting each chronic disease group among the newly sick-listed and the general population#
Men Women
Newly sick listed
n = 1 073
% (95% C.I)
General population
n = 1 730
% (95% C.I)
Difference
% (95% C.I.)
Newly sick listed
n = 2 131
% (95% C.I)
General population
n = 2 145
% (95% C.I)
Difference
% (95% C.I.)
Neoplastic disease 3.2 (2.1–4.2) 0.7 (0.3–1.1) 0.03 (0.01–0.04)* 4.1 (3.2-4.9) 0.9 (0.5–1.3) 0.03 (0.02–0.04)*
Endocrine 5.5 (4.1–6.9) 3.2 (2.4–4.1) 0.02 (0.01–0.04)* 8.2 (7.0–9.3) 5.2 (4.2–6.1) 0.03 (0.02–0.04)*
Psychiatric 8.4 (6.7–10.0) 4.1 (3.2–5.0) 0.04 (0.02–0.06)* 11.4 (10.0–12.8) 6.9 (5.8–8.0) 0.05 (0.03–0.06)*
Neurologic 4.1 (2.9–5.3) 2.4 (1.7–3.2) 0.02 (0.00–0.03) 4.3 (3.5–5.2) 3.3 (2.5–4.0) 0.01 (0.00–0.02)
Cardiovascular 16.8 (14.5–19.0) 9.8 (8.4–11.2) 0.07 (0.04–0.10)* 10.5 (9.2–11.8) 7.4 (6.3–8.5) 0.03 (0.01–0.05)*
Pulmonary 10.4 (8.6–12.3) 11.0 (9.6–12.5) −0.01 (−0.03–0.02) 13.8 (12.3–15.3) 13.1 (11.7–14.5) 0.01 (−0.01–0.03)
Gastrointestinal 12.6 (10.6–14.6) 7.6 (6.3–8.8) 0.05 (0.03–0.07)* 15.4 (13.9–17.0) 12.1 (10.7–13.5) 0.03 (0.01–0.05)*
Skin and allergic 8.1 (6.5–9.7) 7.0 (5.8–8.2) 0.01 (−0.01–0.03) 10.5 (9.2–11.8) 10.7 (9.4–12.0) 0.00 (−0.02–0.02)
Musculoskeletal 21.5 (19.1–24.0) 14.4 (12.8–16.1) 0.07 (0.04–0.10)* 29.1 (27.2–31.0) 20.0 (18.4–21.7) 0.09 (0.07–0.12)*
Rheumatic 2.8 (1.8–3.8) 1.4 (0.8–2.0) 0.01 (0.00–0.03) 6.5 (5.5–7.6) 3.9 (3.1–4.7) 0.03 (0.01–0.04)*
Gynaecologic – – 5.0 (4.1–5.9) 3.9 (3.1–4.6) 0.01 (0.00–0.02)
Other 5.2 (3.9–6.5) 2.8 (2.0–3.5) 0.02 (0.01–0.04)* 3.3 (2.6–4.1) 2.6 (1.9–3.2) 0.01 (0.00–0.02)
No Disease 33.2 (30.4–36.0) 54.2 (51.8–56.5) −0.21 (−0.25– -0.17)* 29.1 (27.2–31.1) 45.7 (43.6–47.8) −0.17 (−0.19– -0.14)*
One chronic disease 44.7 (41.8–47.7) 32.6 (30.4–34.8) 0.12 (0.08–0.16)* 37.8 (35.8–39.9) 32.3 (30.3–34.3) 0.06 (0.03–0.08)*
More than one
chronic disease
22.1 (19.6–24.6) 13.2 (11.6–14.8) 0.09 (0.06–0.12)* 33.0 (31.0–35.0) 22.0 (20.3–23.8) 0.11 (0.08–0.14)*
#Numbers are percentages with 95% confidence intervals in brackets. Significant difference between the two samples is marked with an asterisk (*).
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sick-listed had 40-50% higher risk of co-morbidity com-
pared with the general population (SIR 1.4 for women and
1.5 for men) and were less likely to report no chronic dis-
ease (SIR 0.7 for women and SIR 0.6 for men).0%
10%
20%
30%
40%
50%
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100%
Newly sick-listed sample
Figure 1 Self-report of chronic diseases among the newly sick-listed a
each chronic disease group within the newly sick-listed sample and the ge
Confidence intervals.Discussion
This study offers an assessment of the cumulative inci-
dence of all-cause sickness absence as well as the burden
of chronic disease amongst the same individuals. The re-
sults of men and women differed in all age groups andGeneral population sample
nd the general population. Detailed legend: Proportion reporting
neral population sample are displayed. Error bars represent 95%
Table 4 Burden of chronic disease among the newly sick-listed compared to the general population sample#
Standardized by age groups Standardized by age and socio-economic groups Standardized by age, socio-
economic groups and gender
Men Women Men Women Total sample
Expected
number
of cases
Observed
number
of cases
Standardized
incidence
ratio (95% C.I)
Expected
number
of cases
Observed
number
of cases
Standardized
incidence
ratio (95% C.I)
Expected
number
of cases
Observed
number
of cases
Standardized
incidence
ratio (95% C.I)
Expected
number
of cases
Observed
number
of cases
Standardized
incidence
ratio (95% C.I)
Expected
number
of cases
Observed
number
of cases
Standardized
incidence
ratio (95% C.I)
Neoplastic 9 34 4.0 (2.7–5.3)* 20 87 4.3 (3.4–5.2)* 8 33 4.2 (2.8–5.6)* 20 85 4.3 (3.4–5.2)* 1491 977 0.7 (0.6–0.7)*
Endocrine 41 59 1.4 (1.1–1.8)* 120 174 1.5 (1.2–1.7)* 38 58 1.5 (1.2–1.9)* 118 174 1.5 (1.3–1.7)* 314 403 1.3 (1.2–1.4)*
Psychiatric 44 90 2.0 (1.6–2.4)* 148 243 1.6 (1.5–1.8)* 41 87 2.1 (1.7–2.6)* 140 241 1.7 (1.5–1.9)* 386 406 1.1 (1.0–1.1)*
Neurologic 27 44 1.6 (1.2–2.1)* 73 92 1.3 (1.0–1.5) 26 42 1.6 (1.1–2.1)* 70 92 1.3 (1.1–1.6)* 297 311 1.0 (0.9–1.2)
Cardiovascular 130 180 1.4 (1.2–1.6)* 184 223 1.2 (1.1–1.4)* 124 173 1.4 (1.2–1.6)* 180 221 1.2 (1.1–1.4)* 642 851 1.3 (1.2–1.4)*
Pulmonary 109 112 1.0(0.9–1.2) 278 294 1.1 (0.9–1.2) 108 110 1.0 (0.8–1.2) 274 293 1.1 (1.0–1.2) 108 169 1.6 (1.3–1.8)*
Gastrointestinal 87 135 1.5 (1.3–1.8)* 255 328 1.3 (1.2–1.4)* 81 131 1.6 (1.4–1.9)* 249 325 1.3 (1.2–1.4)* 100 136 1.4 (1.1–1.6)*
Skin and
allergic
76 87 1.1 (0.9–1.4) 221 224 1.0 (0.9–1.1) 72 84 1.2 (0.9–1.4) 223 222 1.0 (0.9–1.1) 192 333 1.7 (1.6–1.9)*
Musculoskeletal 174 231 1.3 (1.2–1.5)* 467 620 1.3 (1.2–1.4)* 166 228 1.4 (1.2–1.5)* 456 615 1.3 (1.3–1.4)* 161 233 1.4 (1.3–1.6)*
Rheumatic 17 30 1.7 (1.1–2.4)* 91 139 1.5 (1.3–1.8)* 17 30 1.8 (1.2–2.4)* 83 139 1.7 (1.4–2.0)* 29 121 4.2 (3.5–4.9)*
Gynaecologic – – – 80 106 1.3 (1.1–1.6)* – – – 79 105 1.3 (1.1–1.6)* 343 463 1.4 (1.2–1.5)*
Other 32 56 1.7 (1.3–2.2)* 57 71 1.2 (1.0–1.5) 32 54 1.7 (1.2–2.1)* 55 70 1.3 (1.0–1.6) 80 106 1.3 (1.1–1.6)*
No Disease 552 356 0.6 (0.6–0.7) 939 621 0.7 (0.6–0.7) 542 347 0.6 (0.6–0.7) 940 613 0.7 (0.6–0.7) 1563 977 0.6 (0.6–0.7)*
One chronic
disease
364 480 1.2 (1.2–1.4)* 696 806 1.2 (1.1–1.2)* 357 469 1.3 (1.2–1.4)* 683 795 1.2 (1.1–1.2)* 1033 1286 1.2 (1.2–1.3)*
More than
one chronic
disease
157 237 1.5 (1.3–1.7)* 496 704 1.4 (1.3–1.5)* 150 230 1.5 (1.4–1.7)* 484 700 1.4 (1.4–1.5)* 607 941 1.5 (1.5–1.6)*
#Standardized incidence ratios (SIR) for chronic disease in the newly sick-listed sample are shown. If the SIR is 1.0 the incidence among the newly sick-listed equals that of the general population sample. A significant
difference (*) between the two samples is observed when the 95% confidence interval does not include 1.0.
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listed than in the general population.
Information on incidence of sickness absence is import-
ant to grasp the size of the problem in terms of number of
individuals involved, especially when following the develop-
ment of sickness absence or planning preventive measures
[36]. Previous research has often focused on self-reported
sickness absence, sickness absence duration or on certain
groups of employees or diseases, thereby portraying differ-
ent aspects of the problem, not always easy to compare to
other results.
The one-year cumulative incidence in this study was
11.3%, meaning that 75,600 individuals in Västra Götaland
region would be sick-listed for a period lasting ≥14 days at
least once annually. The cumulative incidence of sickness
absence was studied in Sweden and Norway in the 1980’s
and the 1990’s [37,38]. However, changes in both society
and social insurance have taken place since then making
comparisons difficult [39]. A study by Lidwall and
Marklund (2010) showed great variation in the number of
ongoing sickness absence cases over the years 1992–2008,
underscoring the inherent difficulty in comparing different
periods [40]. Eriksson et al. (2008) found that 40% of
workers reported any sickness absence during the previous
year, while only 4% had been absent over 29 days, a figure
comparable to ours [41]. Findings from Denmark show that
the cumulative incidence of sickness absence (also of a
minimum of two weeks) among employed people increased
from 6.6% to 7.5% between 2000 and 2007, which is slightly
lower than our findings [42].
Our results show that the cumulative incidence of
sickness absence increased in the older age groups ap-
proaching retirement for both genders. This is not unex-
pected since medium and long term sickness absence is
more common in older age group. Sweden has high em-
ployment rates overall and in older age groups [2], which
means that more employees with health problems might
be present in the workforce compared to other countries
[3]. This can be one reason for the higher sickness ab-
sence levels in Sweden. The ageing of the population
and the trend towards a higher retirement age may also
lead to increased numbers of individuals with chronic
disease in the workforce [43].
With respect to the gender difference by age, the cumu-
lative incidence among women increased stepwise between
age groups, whereas amongst men the most prominent dif-
ference was between the middle and the oldest age groups.
A Norwegian study found that women <50 years of age
and sick-listed >8 weeks due to musculoskeletal disorders
had a higher risk of chronicity than men in the same age
group [44]. The authors suggest that women may develop
chronic musculoskeletal disorders at an earlier age than
men. With respect to the current study, the substantial in-
crease in cumulative incidence of sickness absence amongwomen aged 31–50 years compared with men in the simi-
lar age group may be influenced by the phenomenon of
earlier chronicity. Moreover, women in this particular age-
group are often engaged in both work and family.
According to the double burden hypothesis, women com-
bining careers with responsibility for children and domestic
work may face a higher risk of sickness absence [45]. In a
Swedish longitudinal study women taking on a parental
role during follow up had increased odds for sickness ab-
sence compared to those not adding such a role [46].
Other studies have also linked having young children to in-
creases in sickness absence for women, however this has
also been seen for men [13].
The labour market in Sweden is highly gender segre-
gated. Women and men tend to work in different sectors
(horizontal segregation) and men tend to have higher
positions in the workplace and the occupational hier-
archy (vertical segregation). Both horizontal and vertical
segregation seem to influence sickness absence rates
[13,47]. A Finnish study found that the overall gender
differences in sickness absence can be explained by the
fact that it is more common that women have shorter
absences [48]. This does not seem to apply to our results
as the gender difference was apparent despite exclusion
of shorter absence periods.
In the current study, gender differences in relation to
the different self-reported chronic disease groups were
in line with what has been observed previously in
Sweden (age group 35–64 years), where chronic muscu-
loskeletal, gastrointestinal and psychiatric symptoms as
well as rheumatoid arthritis, were more prevalent among
women [49]. Significantly more men reported having
cardiovascular disease than women, correlating with the
fact that women have been found to develop cardiovas-
cular disease 7–10 years later in life than men [50]. The
importance of chronic disease as a contributory factor to
gender differences has not been much explored. A
Swedish study proposes a triple burden for women and
men with chronic disease added to the demands experi-
enced from paid and unpaid work [51]. Women more
often than men experience a double burden in daily life.
The presence of chronic disease as a third burden may
render women more vulnerable to the work-related bur-
den and place them at increased risk for sickness
absence.
In general, the newly sick-listed reported more chronic
disease and were more likely to have co-morbid diseases
than the random general population sample. The most
commonly reported chronic diseases in the sick-listed
group were musculoskeletal, gastrointestinal, psychiatric
and cardiovascular diseases. Studies have suggested that
complex symptoms such as musculoskeletal pain, digest-
ive problems and mental problems are the leading
causes of sickness absence [52]. These conditions display
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bination and may share a common mechanism of origin.
In the current study, the high burden of musculoskeletal,
gastrointestinal, psychiatric and co-morbid conditions
among the sick-listed may be interpreted with this in
mind. The higher disease burden when compared with
the general population remained consistent throughout
standardisation for age and socio-economic status. There
are few studies examining the burden of sickness ab-
sence among individuals with chronic disease. A study
on individuals with angina pectoris found an almost
threefold higher rate of sickness absence compared with
a sample not suffering from chronic disease [24]. Similar
results have also been reported for fibromyalgia and
asthma [27,28].
There seems to be an even higher risk when more than
one chronic disease is present [24,27,28]. In the current
study we found a substantially increased risk of having co-
morbid diseases among the newly sick-listed compared
with the general population. The reporting of neoplasia
was nearly four times higher which might reflect that most
individuals diagnosed with a malignancy become sick-
listed. This might be due to severe physical symptoms and
the difficult treatments together with the psychological and
social impacts associated with this disease [53]. Sick-listed
men and women had an increased risk of reporting psychi-
atric disease, rheumatic disease and endocrine disease and
sick-listed men had a substantially higher risk of reporting
neurologic disease. These findings show that the burden of
chronic diseases seemed to be significantly higher among
newly sick-listed individuals compared with the general
population, and that this difference was not explained by a
different composition of the newly sick-listed population
when it comes to sex, age or socio-economic status. It is
also noteworthy that this result held true when standard-
ized for socio-economic status in addition to age compared
to standardizing for age alone indicating that those with a
chronic disease are more likely to become sickness absent,
regardless of socio-economic class.Strengths and weaknesses
A major strength of the current study was the inclusion
of all newly sick-listed individuals with employment pro-
viding a population based estimate of the cumulative in-
cidence of sickness absence. Demographic information
and socio-economic status were derived from highly reli-
able Statistics Sweden register data. A possible weakness
in our methodology is an underestimation of the cumu-
lative incidence if part of the working population was
not at risk, possibly due to sickness absence.
The estimation of the one-year cumulative incidence
might be subject to error due to seasonal variation. Sick-
ness absence rates are lower during the second and thirdquarters and higher in the first and fourth quarters [54].
The sickness absence cases included in this study were
spread over the second part of the first quarter and the first
half of the second quarter. It is therefore likely that the ef-
fects of seasonal variation in the current study were mini-
mized. A study from 1974 addressed seasonal variation in
all-cause sickness absence specifically and found that most
seasonal variation was due to upper respiratory disease and
bronchitis in addition to digestive disorders [55]. This
strengthens the assumption that the effects of seasonal
variation in this study ought to have been minimal as sick-
ness absence due to respiratory infections or gastroenteritis
rarely exceeds two weeks [56] and would therefore not
have affected our results.
Data in the second part of the study is based on self-
reported data and there are several potential causes for
bias. There was a drop-out in the first phase of partici-
pant inclusion. Not all individuals sick-listed between
the 18th of February and the 15th of April 2008 were for-
mally registered during the period and included in our
study. The delay was primarily for administrative reasons,
such as determination of income in order to calculate the
appropriate sickness benefit. In our study we nevertheless
include 49% of the sick-listed during the period, which is a
large sample size. The group with later registration had a
higher proportion of individuals with low income, of men
(male/female ratio 1.32), of highly educated and first time
sick-listed as well as a slight overrepresentation of immi-
grants (immigrant/non-immigrant ratio 1.08) according to
our correspondence with the Department for Statistics
and Analysis at the Swedish Social Insurance Agency. Un-
fortunately more detailed statistical information is unavail-
able at this time from the agency. Thus no information is
available regarding any difference in the diagnostic groups
dependent on the time of registration. Therefore there is a
possibility for a systematic bias based on differences in
registration date which we cannot completely exclude.
This risk is somewhat offset by the large sample size but
the smaller diagnostic groups (for example neoplastic dis-
ease) would be more sensitive to any such error.
Another possible source of bias is the relatively low re-
sponse rate which may have led to a selection bias. The
non-response rate was highest in the youngest age
group, those with the lowest income and those born out-
side of the Nordic countries. The results are therefore
less applicable to those groups. The results should also
be interpreted in the light that the selection bias could
also be affected by other variables not captured by the
non-response analyses from Statistics Sweden. Informa-
tion on chronic diseases and conditions was based on
self-reported data so recall and reporting bias may there-
fore have occurred. Those who were sick-listed or had
recently been sick-listed may have been more prone to
remembering or reporting chronic diseases. This could
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dence ratios. A health response bias might also be
present, with the healthiest individuals responding. Sen-
sitivity and specificity of self-reported data on chronic
disease has been found to vary from one disease group
to another, with data for cardiovascular disease, diabetes
and cancer being most reliable [57,58] while data for
musculoskeletal [58] and psychiatric [59] disorders is less
reliable [58]. Musculoskeletal disorders had the highest
frequency in both samples and even if all of these might
not be confirmable with clinical examination, these results
give insight into the subjective experience of musculoskel-
etal problems among the sick-listed and the general popu-
lation. The frequencies of psychiatric disorders in both
samples are lower than the 15-25% 12 month prevalence
of mental disorders reported by the WHO [60]. This may
be due to responders being less likely to disclose mental
health problems due to stigma and the results should be
interpreted with the possibility of underestimation of psy-
chiatric problems in mind.
Finally, the newly sick-listed sample was composed
solely of employed individuals while the general popula-
tion sample was a random sample of the total population.
While we have corrected for the differences in age and so-
cioeconomic position between the groups with standard-
isation for these factors, we cannot however rule out the
possibility of other variations between the groups, some of
which might affect our results. This is a possible major
limitation of our study, which is however difficult to avoid
when seeking a comparison group for the sick-listed popu-
lation. An example of this type of effect is that we may
have underestimated the differences between the newly
sick-listed employed population and the general popula-
tion as the employed population was a healthier group
than the general population, which included the un-
employed, individuals on disability pension as well as indi-
viduals on recurrent or long-term sick-leave.
Conclusion
The current study gives an estimate of cumulative inci-
dence of sickness absence among the working population
in western Sweden. Our results indicate that the newly
sick-listed working population had a higher rate of fre-
quently reported chronic diseases, such as musculoskeletal,
gastrointestinal, mental and cardiovascular disorders than
the general population. The study results also show im-
portant age-related gender differences in sickness absence
and burden of disease, and points to women’s multiple
roles in society as one potential explanation. The study
highlights the importance of taking health status into ac-
count when designing preventive interventions. Targeting
these long-term health problems may be an important fac-
tor in any attempt to decrease sickness absence.Additional file
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